Cargando…
Oral Adelmidrol Administration Up-Regulates Palmitoylethanolamide Production in Mice Colon and Duodenum through a PPAR-γ Independent Action
Adelmidrol is a promising palmitoylethanolamide (PEA) analog which displayed up-and-coming anti-inflammatory properties in several inflammatory conditions. Recent studies demonstrated that Adelmidrol is an in vitro enhancer of PEA endogenous production, through the so called “entourage” effect. The...
Autores principales: | Del Re, Alessandro, Palenca, Irene, Seguella, Luisa, Pesce, Marcella, Corpetti, Chiara, Steardo, Luca, Rurgo, Sara, Sarnelli, Giovanni, Esposito, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144287/ https://www.ncbi.nlm.nih.gov/pubmed/35629962 http://dx.doi.org/10.3390/metabo12050457 |
Ejemplares similares
-
Ultramicronized Palmitoylethanolamide Inhibits NLRP3 Inflammasome Expression and Pro-Inflammatory Response Activated by SARS-CoV-2 Spike Protein in Cultured Murine Alveolar Macrophages
por: Del Re, Alessandro, et al.
Publicado: (2021) -
N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism
por: Palenca, Irene, et al.
Publicado: (2022) -
Cannabidiol inhibits SARS‐Cov‐2 spike (S) protein‐induced cytotoxicity and inflammation through a PPARγ‐dependent TLR4/NLRP3/Caspase‐1 signaling suppression in Caco‐2 cell line
por: Corpetti, Chiara, et al.
Publicado: (2021) -
Next-Generation Probiotics for Inflammatory Bowel Disease
por: Pesce, Marcella, et al.
Publicado: (2022) -
Nutraceuticals and Diet Supplements in Crohn’s Disease: A General Overview of the Most Promising Approaches in the Clinic
por: De Conno, Barbara, et al.
Publicado: (2022)